Back to Browse Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
2,177 Dovepress* 1,879 297+ 222 2,176
PubMed Central* 0 1 2 1
Totals 1,879 298 224 2,177
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
210 0 0 0 2 208

View citations on PubMed Central and Google Scholar